These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Uricoeliminating or urico-inhibiting agents? Reasons for a choice]. Cottin S, Prost A. Sem Hop; 1972 May 20; 48(24):1739-42. PubMed ID: 4340887 [No Abstract] [Full Text] [Related]
34. Pathogenesis, clinical findings and management of acute and chronic gout. Corrado A, D'Onofrio F, Santoro N, Melillo N, Cantatore FP. Minerva Med; 2006 Dec 20; 97(6):495-509. PubMed ID: 17213786 [Abstract] [Full Text] [Related]
37. [What is certain in gout therapy?]. Gottesbüren H, Strohmeyer G. Internist (Berl); 1971 Dec 20; 12(12):518-21. PubMed ID: 4945391 [No Abstract] [Full Text] [Related]
38. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases. Rozenberg S, Roche B, Dorent R, Koeger AC, Borget C, Wrona N, Bourgeois P. Rev Rhum Engl Ed; 1995 May 20; 62(5):392-4. PubMed ID: 7655872 [Abstract] [Full Text] [Related]
39. [Gout. Clinical analysis of 300 cases of urate gout]. Rapado A. Rein Foie; 1968 May 20; 11():63-92. PubMed ID: 5309150 [No Abstract] [Full Text] [Related]
40. The management of gout at an academic healthcare center in Beijing: a physician survey. Fang W, Zeng X, Li M, Chen LX, Schumacher HR, Zhang F. J Rheumatol; 2006 Oct 20; 33(10):2041-9. PubMed ID: 17014019 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]